Pilot study of flesinoxan, a 5-HT1A agon
β
Marc Ansseau; William Pitchot; Antonio Gonzalez Moreno; Jacques Wauthy; Patrick
π
Article
π
1993
π
John Wiley and Sons
π
English
β 378 KB
π 1 views
Flesinoxan is a highly potent and selective 5-HTlA full agonist, active in several models of depression. In this pilot open study, flesinoxan (4 mdd) was administered orally for 4 weeks in 16 major depressive, mostly treatmentresistant inpatients exhibiting a score of at least 19 on the Hamilton dep